vaers under reporting

vaers (vaccine adverse events reporting system) is the voluntary system used in the u.s. to signal vaccine side effects. during the 18-year period from 1990 through 2007 just 88 cases of kawasaki disease in children under 5 were reported to vaers. (pediatr infect dis j 28:943, 2009) from 1988 to 2006 the published kd incidence for u.s. children under 5 rose from 11.0 to 20.8 per 100,000 person-years.

trial that found a 5-fold kd risk associated with rotateq–rr=4.9; 95% ci 0.6, 239. if confirmed by a larger trial, the kd risk associated with rotateq would translate to an extra 4000 u.s. cases annually in young children. i know that this discussion began with febrile convulsions in young children given seasonal flu vaccine, but the problems way the data are used by public health officials and the vaccine industry apply to other vaccines and other serious clinical problems.

it was also suggested that more efforts be made to educate adult vaccines about the possible adverse effects of vaccines. a vaccine researcher noted that physicians have vaccine information statements that they can give to the parents of children being vaccinated, but that such statements for adults about to be vaccinated are less common and not as readily available. to improve further the quality of information in vaers reports, a consumer representative suggested that the person assigned to follow up death reports speak to both the parent of the child and the child’s physician to obtain more details about the adverse event. a cdc representative suggested that for those reported adverse events for which there are established diagnostic criteria (e.g., anaphylaxis or multiple sclerosis), a standard follow-up protocol should be sent to the reporter and the physician. a participant suggested that vaers be made more effective by committing more u.s. department of health and human service funds to increase the staffing and other resources needed to detect and respond to adverse events more expeditiously.

to better assess vaccine lot administration, a cdc representative suggested that vaccine manufacturers include postcards in some of the boxes of vaccines distributed. to further identify adverse reactions to vaccines, an fda representative suggested that larger clinical trials of vaccines be performed before the vaccines are licensed for general use. even if a vaccine is shown to be safe in a large clinical trial, the potential for lot and batch variability and for variability in the use of vaccines require continual surveillance for adverse events. to better separate the adverse effects of a vaccine from background adverse events that occur in the age group vaccinated, a vaccine researcher suggested that different vaccine schedules be used for different groups of children in a random manner. the toll-free telephone number for the national vaccine injury compensation program is (800) 338-2382. the number for the vaccine adverse events reporting system is (800) 822-7967. institute of medicine (us) board on health promotion and disease prevention.

reports of all possible associations between vaccines and adverse events (possible side effects) are filed in vaers. therefore, vaers collects data on any peter collignon and his colleagues do not exaggerate the problem of adverse event underreporting. vaers (vaccine adverse events reporting vaers, lldb, vaccine manufacturer surveillance measures, and fda response procedures have several limitations. speakers and participants voiced several, .

he announced that almost 4000 people had died after getting covid-19 vaccines, and added that those data “comes from vaers,”—the vaccine adverse event reporting an article widely shared on social media claims more than 150000 people have died from covid-19 vaccines. the u.s. food and drug is it true that vaers says 3000 people have died from the covid-19 vaccines?, .

When you try to get related information on vaers under reporting, you may look for related areas. .